Sleep Apnea in Children with Down Syndrome: Why Annual Screening Saves Lives
Up to 80 percent of children with trisomy 21 develop obstructive sleep apnea. European pediatric guidelines now mandate proactive screening, and treatment can transform development, growth, and family life.
Sleep apnea in children with Down syndrome is one of the most underrecognised pediatric health risks in Europe. Up to 70 to 80 percent of children with trisomy 21 develop obstructive sleep apnea (OSA) during childhood, yet many are diagnosed late because symptoms can look like ordinary toddler restlessness or behaviour issues. The European Society for Paediatric Otorhinolaryngology and the European Academy of Paediatrics now recommend universal screening from age 4. To understand pediatric OSA more broadly, see recognising sleep apnea in children.
This guide explains the unique anatomy that drives high OSA rates, the European screening timeline, the diagnostic process from polysomnography to treatment, and the family resources that help across major EU countries. It is written for parents, caregivers, and clinicians who want a clear, evidence-based map of the pediatric OSA pathway in Down syndrome.
- OSA prevalence in Down syndrome reaches 70 to 80 percent at some point in childhood.
- Anatomy explains the risk: midface hypoplasia, macroglossia, hypotonia, large adenoids and tonsils.
- European pediatric guidelines mandate sleep study by age 4.
- Early treatment improves cognition, behaviour, growth, and cardiovascular health.
Why Down syndrome creates a perfect storm for OSA
Children with trisomy 21 carry several overlapping airway and physiological features. Each one alone could narrow the upper airway. Together they make nighttime obstruction nearly universal at some stage.
Midface hypoplasia
The middle face grows less than expected, producing a smaller upper airway and crowded nasal passages from infancy through adolescence.
Relative macroglossia
The tongue is normal-sized but sits in a smaller oral cavity, so it crowds the airway. It also tends to fall back during sleep due to low tone.
Hypotonia
Generalised low muscle tone affects the pharyngeal muscles. The airway collapses more easily during inhalation, especially in deeper sleep stages.
Adenotonsillar hypertrophy
Adenoids and tonsils grow rapidly between ages 2 and 8 and are proportionally larger in many children with Down syndrome.
Narrow nasal passages
Combined with frequent rhinitis and reduced ciliary function, the nose offers more resistance to inflow than in typically developing peers.
Obesity risk
Approximately 30 to 50 percent of adolescents with Down syndrome are above the 95th centile for weight, adding fat to neck and pharyngeal tissues.
The European pediatric guideline and screening timeline
The European Society for Paediatric Otorhinolaryngology (ESPO) and the European Academy of Paediatrics (EAP) endorse the use of structured screening from infancy onwards. Several national pediatric societies in Europe (France, Germany, Italy, Spain, Netherlands, UK) build on this framework. The core message is consistent: screen early, screen often, intervene fast.
Recommended timeline
| Age | Action | What it covers |
|---|---|---|
| 0 to 12 months | Symptom review at every well-baby visit | Snoring, breathing effort, feeding pauses |
| 1 to 3 years | Annual symptom review + ENT referral if any concern | Snoring, witnessed apnea, restless sleep, growth |
| By age 4 | Baseline polysomnography | Whether or not symptoms are reported |
| 4 to 12 years | Annual sleep symptom review + repeat study after intervention | Behavior, attention, growth, school performance |
| Adolescence | Repeat polysomnography around puberty | Capture changes from growth, weight, hormone shifts |
What to look for in your child
Symptoms in young children rarely match the adult picture. Daytime sleepiness is uncommon. Instead, behaviour and growth tell the story.
Nighttime signs
- Loud snoring most nights at any age.
- Witnessed pauses in breathing.
- Restless sleep with frequent position changes.
- Mouth breathing or visible neck extension to keep airway open.
- Sweating at night, often around the head.
Daytime signs
- Hyperactivity, irritability, or attention problems.
- Slowing of growth on the centile charts.
- Frequent ear infections.
- Falling behind in developmental milestones.
- Morning headaches in older children.
- Record a 30-second video of your child's breathing during sleep.
- Bring it to the pediatrician along with a 1-week sleep diary.
- Use specific descriptions, not "they sleep badly".
- Ask for the ESPO or national pediatric sleep guideline by name. It exists in writing.
- Track behaviour, school performance, and weight to support the case.
How European pediatric sleep studies work
Polysomnography in young children differs from adult tests. It is performed in a dedicated pediatric sleep laboratory by trained technologists.
What happens at the test
- The family arrives in the early evening for a one-night admission.
- Sensors are applied: head EEG, eye movement, ECG, chin tone, leg movement, airflow, abdominal and chest belts, oxygen saturation.
- The child sleeps in a calm room with a parent.
- The technologist monitors continuously to record the apnea-hypopnea index, oxygen profile, and sleep stages.
- A pediatric sleep specialist reviews and reports within 1 to 2 weeks.
Pediatric AHI thresholds (different from adults)
| Severity | AHI events per hour |
|---|---|
| Normal | Less than 1 |
| Mild OSA | 1 to 4.9 |
| Moderate OSA | 5 to 9.9 |
| Severe OSA | 10 or more |
Treatment options at every level
Treatment depends on the severity, the underlying cause, and the child's age and weight. The team usually includes a pediatric ENT, sleep medicine specialist, dietician where weight is a factor, and developmental pediatrician.
First-line: adenotonsillectomy
Surgical removal of adenoids and tonsils is the most common first treatment in children with Down syndrome and OSA, performed at a pediatric ENT centre. Across European cohorts, adenotonsillectomy fully resolves OSA in roughly 30 to 50 percent of children with trisomy 21, lower than in typically developing children because of the multifactorial anatomy. A repeat polysomnography 3 to 6 months postoperatively confirms results.
Second-line: positive airway pressure (PAP)
If significant OSA persists after surgery, CPAP is the standard. Modern pediatric machines are quiet, with humidifiers and sized masks for small faces. Adherence improves with family support, gradual desensitisation, and behavioural play. EU public systems cover the rental and supplies for diagnosed pediatric OSA.
Third-line and adjuncts
- Weight management programmes for adolescents with high BMI.
- Mandibular advancement splints in older adolescents and adults.
- Hypoglossal nerve stimulation (Inspire EU) — approved in 2023 for selected adolescents with Down syndrome aged 13 to 18 with residual OSA.
- Surgical airway adjustment (rarely, in complex anatomical cases).
- Treatment of contributing factors: rhinitis, allergies, obesity, hypothyroidism, gastroesophageal reflux.
Why early treatment matters so much
OSA in children with Down syndrome is not a quality-of-life issue alone. It interacts with development and physiology in ways that change long-term outcomes.
Cognition and behaviour
Untreated OSA reduces attention span, working memory, and language skills. In children already navigating learning differences, OSA often compounds the challenge. Studies in European pediatric sleep cohorts show measurable improvements in attention scores within 6 months of effective treatment.
Growth
Disrupted slow-wave sleep reduces growth hormone secretion. Children with persistent OSA tend to plateau on the centile chart. Treatment often produces a growth catch-up over the following 6 to 12 months.
Cardiovascular health
Recurrent oxygen drops increase pulmonary artery pressure. Children with Down syndrome already have a higher baseline cardiac risk, including congenital heart defects. Treating OSA reduces pulmonary hypertension risk and supports overall cardiac function. For more on the heart-sleep link, see sleep apnea and heart disease.
Quality of life for the family
Better sleep for the child means better sleep for caregivers. Parental fatigue is one of the strongest predictors of family stress. Treatment is therefore a family intervention, not just a child intervention.
Family resources across Europe
Several European organisations support families navigating Down syndrome and OSA. Use them for peer support, advocacy, and country-specific care navigation.
European Down Syndrome Association (EDSA)
Pan-European federation of national groups. Aggregates research, advocacy, and educational materials in many languages.
Down Syndrome International
Global advocacy body with European partners. Position papers on health surveillance and rights.
Trisomie 21 France
National federation. Coordinates with French CHU pediatric sleep centres.
Deutsches Down-Syndrom InfoCenter
German information hub. Links to local pediatric sleep clinics and family groups.
Down's Syndrome Association (UK)
Provides health surveillance guidance aligned with NHS pathways.
Stichting Downsyndroom (NL)
Dutch foundation focused on practical support and integration with regional sleep centres.
- Has my child had a baseline polysomnography by age 4?
- What is the local pediatric sleep clinic and how do I refer?
- If we treat, when will we repeat the sleep study?
- How do we coordinate ENT, sleep medicine, and cardiology?
- Where can I find peer-support resources for our family?
Frequently asked questions
How common is sleep apnea in children with Down syndrome?
Obstructive sleep apnea affects 70 to 80 percent of children with Down syndrome at some point during childhood. Prevalence is highest between ages 2 and 8. The European Society for Paediatric Otorhinolaryngology recommends screening from age 4 onward, even in the absence of symptoms.
Why is sleep apnea so common in trisomy 21?
Children with Down syndrome combine several anatomical and physiological factors that narrow the upper airway: midface hypoplasia, large tongue (relative macroglossia), low muscle tone (hypotonia), high palate, large adenoids and tonsils, and increased risk of obesity. These overlap to make obstruction very likely.
When should screening for sleep apnea start?
European pediatric guidelines recommend a baseline polysomnography by age 4 in all children with Down syndrome, even without symptoms. Earlier studies are warranted if witnessed apnea, restless sleep, or daytime symptoms appear. Annual review of sleep symptoms continues throughout childhood.
What does treatment look like for these children?
Treatment typically starts with adenotonsillectomy, which resolves OSA in 30 to 50 percent of cases. Residual OSA is treated with weight management, positional therapy, mandibular advancement (older children), CPAP, and selected pediatric hypoglossal nerve stimulation. Care is coordinated through pediatric ENT and pulmonology teams.
Will my child need CPAP forever?
Not always. Many children outgrow CPAP after surgery, growth, or weight management. Others use it long-term, particularly through adolescence. Annual sleep studies and clinical review guide tapering. Modern pediatric masks and humidifiers improve comfort and adherence dramatically.
Are nasal stents suitable for children with Down syndrome?
Soft intranasal stents are not a primary treatment for pediatric OSA in Down syndrome. The Back2Sleep stent is indicated for adult snoring and mild to moderate OSA. Pediatric care follows surgical and CPAP pathways supervised by sleep medicine specialists. Always consult the treating team.
How does untreated OSA harm a child with Down syndrome?
Untreated OSA worsens cognitive development, attention, behaviour, growth, cardiovascular health (pulmonary hypertension), and quality of life. Children with Down syndrome already have cardiac and developmental vulnerabilities, so timely OSA management has outsized benefits across many domains.
Where can families find European support?
European Down Syndrome Association (EDSA), national groups like Trisomy 21 France or Down Syndrome International chapters, and pediatric sleep centres in major university hospitals provide reliable resources. Ask your pediatrician for the local sleep medicine network and patient organisation contacts.
This article is for general information only and does not replace medical advice. Consult a qualified healthcare professional in your country for diagnosis and personalised treatment of nasal disorders or sleep apnea.
What Back2Sleep Users Say
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.
